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Open Access

Preliminary evaluation of near infrared
spectroscopy as a method to detect plasma
leakage in children with dengue hemorrhagic
fever
Babs Soller1,2*, Anon Srikiatkachorn3,4, Fengmei Zou1, Alan L Rothman5, In-Kyu Yoon4, Robert V Gibbons4,
Siripen Kalayanarooj6, Stephen J Thomas7 and Sharone Green3

Abstract
Background: Dengue viral infections are prevalent in the tropical and sub-tropical regions of the world, resulting in
substantial morbidity and mortality. Clinical manifestations range from a self-limited fever to a potential life-threatening
plasma leakage syndrome (dengue hemorrhagic fever). The objective of this study was to assess the utility of near infrared
spectroscopy (NIRS) measurements of muscle oxygen saturation (SmO2) as a possible continuous measure to detect
plasma leakage in children with dengue.
Methods: Children ages 6 months to 15 years of age admitted with suspected dengue were enrolled from the dengue
ward at Queen Sirikit National Institute for Child Health. Children were monitored daily until discharge. NIRS data were
collected continuously using a prototype CareGuide Oximeter 1100 with sensors placed on the deltoid or thigh. Daily
ultrasound of the chest and a right lateral decubitus chest x-ray the day after defervescence were performed to detect
and quantitate plasma leakage in the pleural cavity.
Results: NIRS data were obtained from 19 children with laboratory-confirmed dengue. Average minimum SmO2
decreased for all subjects prior to defervescence. Average minimum SmO2 subsequently increased in children with
no ultrasound evidence of pleural effusion but remained low in children with pleural effusion following defervescence.
Average minimum SmO2 was inversely correlated with pleural space fluid volume. ROC analysis revealed a cut-off value
for SmO2 which yielded high specificity and sensitivity.
Conclusions: SmO2 measured using NIRS may be a useful guide for real-time and non-invasive identification of plasma
leakage in children with dengue. Further investigation of the utility of NIRS measurements for prediction and management
of severe dengue syndromes is warranted.

Background
There are approximately 390 million dengue virus
(DENV) infections worldwide, resulting in 500,000
hospitalizations and 20,000 deaths annually [1]. The
mosquito-borne DENV, of which there are four serotypes,
causes substantial morbidity and mortality in tropical
and sub-tropical regions of the world [2]. The clinical
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manifestations of DENV infection range from a self-limited
febrile illness comprising fever, rash, headache and myalgias
known as dengue fever (DF) to a potentially life-threatening
plasma leakage syndrome, dengue hemorrhagic fever
(DHF). In the evaluation of DHF patients, plasma
leakage may manifest as pleural effusion, ascites, or
hemoconcentration [2]. Pleural effusions are a common
sign of plasma leakage in patients with DHF and have
been positively correlated with disease severity [2-4]. If
detected early, the effects of plasma leakage are manageable
with judicious use of intravenous fluids; case-fatality rates
at experienced medical facilities ranges between 0.5% - 1%.
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However, progression to DHF often relies on serial history
and physical examinations and clinical laboratory
evaluations to detect hemoconcentration (rising hematocrit)
and thrombocytopenia. Chest x-ray and ultrasound have
also been shown to be effective in identification of pleural
effusions and/or ascites in DHF patients [3]. While
non-invasive, these measurements are not practical
for prediction of plasma leakage in resource poor settings.
Due to the relatively rapid nature of the onset of shock,
these crude measures may not be done at the appropriate
time to support preventive fluid administration.
Near infrared spectroscopy (NIRS) is a non-invasive
technique which can be used to continuously assess
tissue oxygenation in cerebral as well as in muscle tissue.
It has been widely used on children [5] and has been
shown to have important uses in trauma and critical care
settings [6]. Muscle oxygen saturation (SmO2) is distinct
from tissue oxygen saturation (StO2) in that the determination of oxygenated and deoxygenated hemoglobin is
performed on spectra which have been corrected for
spectral interferences from skin pigment and fat [7].
SmO2 has been shown to be sensitive for the early
detection of hypovolemia by tracking increased oxygen
extraction resulting from peripheral vasoconstriction to
shunt blood to the heart and brain [8-10]. Since decreased
peripheral perfusion is a clinical observation in patients
with DHF [2], we hypothesized that NIRS-determined
SmO2 would be effective in identifying DHF patients with
significant plasma leakage. An easy, non-invasive method
which would permit early (i.e. prior to more tradition
clinical tools) identification of plasma leakage would be an
invaluable tool for early identification of progression to
DHF and support fluid management to prevent shock in
children with severe dengue.

Methods
Study enrollment

Children aged ≥ 6 months and ≤ 18 years of age with
suspected dengue virus infection, temperature ≥38.5°C
within 24 hours of enrollment and no chronic underlying
medical condition were enrolled from the in-patient
dengue ward at the Queen Sirikit National Institute
of Child Health. Subjects were monitored daily until
discharge. Fluid administration and other clinical management were guided by the treating physician according to
WHO guidelines [2]. Disease severity was assigned
according to the 1997 WHO guidelines. Dengue fever
(DF) was defined as confirmed dengue virus infection in
the absence of evidence of plasma leakage. Dengue
hemorrhagic fever (DHF) was defined as plasma leakage
(hemoconcentration ≥ 20% over baseline, pleural effusion,
or ascites) in the presence of thrombocytopenia (platelet
count ≤ 100,000 mm3). Temperature was measured at
least every 6 hours. The day of defervescence, designated
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fever day 0, was the day in which the temperature fell and
remained below 38°C with one and two days prior designated as fever days −1 and −2 etc. and after defervescence
fever days +1, +2, etc. Blood was collected daily for
hematocrit determination. Fever time zero was recorded
as the first temperature recording below 38°C on
fever day 0. Dengue virus infection was confirmed by
RT-PCR and/or dengue serology as previously described
[11,12]. This study was approved by the Institutional
Review Boards of the Queen Sirikit National Institute for
Child Health, the Thai Ministry of Public Health, and the
US Army Surgeon General. Written informed consent was
obtained from the parent or guardian. Assent forms were
obtained from subjects who were at least seven years old.
NIRS data collection

NIRS data were collected with a prototype version of the
CareGuide Oximeter 1100 (Reflectance Medical Inc.,
Westborough, MA, USA). The CareGuide Oximeter uses
two different source-detector separation distances to
correct the spectra for interference from skin and fat.
Incident light is produced by a broad band NIR LED
light source which illuminates the tissue over the range of
700 nm – 900 nm. The sensor has a chip-scale spectrophotometer parallel to a row of light sources spaced at different
distances (6 mm to 45 mm) from the spectrometer. One
light source, placed 6 mm from the spectrometer, collects
light reflected from near the tissue surface, capturing the
spectrum associated with the skin pigment. A series of six
light sources spaced 5 mm apart and 20 mm-45 mm from
the spectrometer are used to illuminate the muscle. The
sensor automatically selects the light source which is at an
appropriate distance to capture light reflected back from
the muscle. Thicker fat layers require longer separations to
increase the depth of penetration into the tissue. The
muscle spectra are corrected by mathematically removing
the spectral information from the skin pigment and
SmO2 is calculated from the isolated muscle spectrum
[13]. Additional details on the device, it’s validation against
venous blood, and performance on healthy adults have
been previously published [14].
The NIRS sensor was adhered to the deltoid or the
thigh with a NIR-transparent double sided adhesive tape
(Figure 1). The sensor is attached by a cable to a 10” touch
screen computer that is mounted at the bedside. The location of the sensor was at the discretion of the study nurse.
The sensor was applied as soon as possible after the child
was admitted to the dengue ward. Data was collected every
5 minutes and a minimum average SmO2 was calculated for
each 30 minute interval using fever time zero as the central
reference point. Monitoring was stopped each day to bathe
the patient and the sensor was then reapplied. If the sensor
came off at night, it was not reapplied until the next morning. Data collection ceased when the child was discharged.
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Table 1 Baseline characteristics of subjects at study entry
Clinical diagnosis at discharge

DF

DHF

8

11

Age (mean ± SE)

10.5 ± 0.3

10.0 ± 0.2

Sex (male/female)

6/2

7/4

39.8 ± 0.3

42.3 ± 0.6

70 ± 11

102 ± 16

0/8

2/7*

4.5 ± 0.1

4.3 ± 0.1

−0.25 ± 0.1

−0.73 ± 0.1

Number of subjects

Hematocrit (%) (mean ± SE)
AST (mean ± SE)
Presence/Absence of pleural effusion
(by ultrasound)
Days ill prior to enrollment (mean ± SE)
Figure 1 Photograph of prototype CareGuide sensor applied to
child’s thigh.

Fever day (mean ± SE)
* Data not available for 2 subjects.

Ultrasound and radiographic data collection

Ultrasonography of the chest and abdomen was performed
by a radiologist daily to assess for pleural effusions. Three
sites on the chest were assessed as previously described [3].
Briefly, ultrasound examinations were performed daily with
a portable ultrasound scanner (GE Logiq Book) using a
2.5 MHz convex transducer. Standard protocols were used
to examine 3 chest sites for fluid accumulation using
mid-axillary-longitudinal, a mid-clavicular-longitudinal,
and right upper quadrant-transverse views. The presence or
absence of fluid in these images was noted by a radiologist
who was blinded to the clinical data. If any of the 3 views
was positive for fluid, the patient was considered to have
pleural effusions on that day.
One day after defervescence (fever day +1), a right lateral
decubitus chest x-ray was obtained. A pleural effusion
index (PEI) was calculated from the maximal height of
pleural fluid/width of hemithorax × 100 [3].

small to accept the sensor. Representative 30 minute
average SmO2 for two subjects, one without and one
with evidence of pleural effusion, collected during the
‘critical period’ from fever day – 1 through fever day +1
are shown in Figure 2.

Data analysis

The minimum average 30-minute SmO2 was determined
for each study day and a receiver operator characteristic
curve (ROC) was constructed to determine the sensitivity
and specificity of SmO2 to detect pleural effusions
observed with the daily ultrasound measurements.
The x-ray determined PEI was compared to the minimum
SmO2 for the same day using linear regression.

Results
Study population

NIR spectra were successfully collected for 19 (13 M/6 F)
patients intermittently over the enrollment period
(range: 2 to 5 days). Patient characteristics at study
enrollment are shown in Table 1. The average patient
age was 10.2 ± 2.6 years. Three of 19 subjects (16%)
progressed to shock. Twelve subjects had the sensor placed
on the arm and 7 subjects had data collected on the thigh.
There was no association between gender and sensor
location, however the thigh placement was used on
the younger subjects, who generally had arms too

Figure 2 Representative plots of minimum average 30 minute
SmO2 for (A) a subject with no pleural effusion detected and (B) a
subject with pleural effusion detected by ultrasound and chest
x-ray. Fever time zero denotes the time of defervescence (temperature
≤38°C). PE = pleural effusion as measured by ultrasound; PEI = pleural
effusion index as measured on right lateral decubitus chest x-ray.
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Association of SmO2 with pleural effusion

Maximal plasma leakage and shock in dengue typically
occurs within 24 hours of defervescence. To compare all
subjects at similar times during their disease progression,
SmO2 was plotted by fever day rather than study day,
where fever day = 0 represents the day of defervescence
(Figure 3). Between fever day −1 and fever day 0, average
minimum SmO2 decreased for all patients; however on
fever day +1, on average, SmO2 increased for patients
without ultrasound evidence of pleural effusion, and
conversely decreased for those patients with evidence
of pleural effusion. Figure 4 shows the relationship
between minimum SmO2 on fever day +1 and the PEI
determined from chest x-ray on that day. We found
an inverse linear relationship between the two parameters
(R2 = 0.61) with low values of SmO2 corresponding to a
high pleural effusion index.
Figure 5 shows the ROC curve for minimum SmO2 as an
indication of pleural effusion detected with ultrasound on
each study day (55 data points). At the SmO2 cut-off value
of 48.3% the sensitivity is 83% and the specificity is 81%.
The area under the ROC curve is 0.81 (95% CI: 0.69 – 0.91).

Discussion
To our knowledge, this is the first study to use NIRS to
evaluate dengue patients for markers of plasma leakage
that may result in shock. Our data show that SmO2
values less than 48% have a high sensitivity and specificity
for being associated with pleural effusions in the study
patients. A tool which permits real time detection of
plasma leakage via SmO2 monitoring may help to
determine which individuals will require earlier fluid
intervention, thereby reducing the number of dengue
patients who proceed to shock.

Figure 3 Minimum daily SmO2 by fever day for patients
without pleural effusions (closed circles) and with pleural
effusions (open circles) determined from ultrasound. Fever
day = 0 is the day of defervescence. Mean ± standard error.

Figure 4 Linear regression of minimum SmO2 with pleural
effusion index (PEI) determined from a chest x-ray taken on the
same day; R2 = 0.61.

Earlier studies using strain gauge plethysmography
demonstrated that pleural effusion in dengue patients
was accompanied by microvascular fluid leakage into the
extravascular space [15]. Recent studies confirm that
pleural effusions were the most common sign of plasma
leakage in DHF patients [3,4]. Plasma leakage may result
in reduced intravascular volume, a higher risk for
shock and thereby reduced SmO2. It has been previously
demonstrated that SmO2 is a very early indicator of
central hypovolemia using a human laboratory model
of pre-shock hemorrhage: lower body negative pressure

Figure 5 Receiver operator characteristic curve for daily
minimum SmO2 as an indicator of pleural effusion. At the SmO2
cut-off value of 48.3%, marked with an open circle, the sensitivity is
83% and the specificity is 81%.
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(LBNP). Significant decreases in SmO2 occurred well
before decreases in blood pressure and arterial oxygen
saturation by pulse oximetry (SpO2) and increases in
heart rate [8,9]. In the LBNP model, decreases in
SmO2 were highly correlated with increases in total
peripheral resistance, indicating that this observed increase
in oxygen extraction results from vasoconstriction that is
shunting blood away from the skeletal muscle toward the
heart in an effort to maintain normal blood pressure [8,10].
In a similar fashion, the decreases in SmO2 observed in
these DHF patients likely result from intravascular volume
depletion and subsequent compensatory vasoconstriction.
In a study by Libraty et al., the ratio of extracellular
to intracellular water (ECW/ICW) was determined by
bioelectrical impedance spectroscopy for patients with
DF, DHF and other febrile illnesses [16]. Around the
time of defervescence, the ECW/ICW ratio increased in
proportion to disease severity. The authors suggested that
the positive fluid balance that accompanied the increase in
extracellular water was due to a reduction in renal water
clearance [16]. An increase in extravascular water could
reduce tissue blood flow and increase oxygen extraction,
thereby lowering SmO2. During the time surrounding
defervescence and fluid administration, it is not known if
the decrease in SmO2 is a result of hypovolemia or excess
interstitial water reducing blood flow. Gaining a better
understanding of this may help in developing tools to
guide fluid resuscitation for dengue patients in a manner
which will avoid fluid overload.
One limitation of this study may be the use of daily
minimum SmO2 for statistical analysis. Patients without
pleural effusion had fewer NIRS readings per day than
patients with pleural effusion, likely because these patients
were less sick and therefore more ambulatory.
This pilot study investigated the noninvasive monitoring
of SmO2 in patients with dengue infection. Low levels of
SmO2 were shown to be associated with pleural effusions
detected with ultrasound and chest x-ray. This technology
provides continuous SmO2 readout to track of the
progression and treatment of patients with diseases which
cause plasma leakage and heightened risk of shock. This
initial study determined a SmO2 cutoff of 48%, but this
value would need to be confirmed in additional dengue
cohorts of both adults and children. Once validated, at
risk patients could be routinely monitored because
the display provides immediate feedback to the clinician.
The SmO2 monitor is significantly lower in cost than
ultrasound equipment, but it is recognized that to be
widely adopted in countries with limited resources the
cost to use it must be modest.

Conclusions
A pilot study of Thai children hospitalized with acute
dengue virus infection demonstrated that minimal daily
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SmO2 as measured by NIRS was found to correlate with
pleural effusions in hospitalized children with acute
dengue virus infection. ROC analysis revealed a cut-off
value for SmO2 (48%) which yielded high specificity and
sensitivity. Further studies to further define and validate
the utility of NIRS monitoring to detect plasma leakage
in dengue are warranted.
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